Logo image of JNJ

JOHNSON & JOHNSON (JNJ) Stock Price, Quote, News and Overview

NYSE:JNJ - New York Stock Exchange, Inc. - US4781601046 - Common Stock - Currency: USD

148.44  -5.7 (-3.7%)

Premarket: 148.98 +0.54 (+0.36%)

JNJ Quote, Performance and Key Statistics

JOHNSON & JOHNSON

NYSE:JNJ (5/13/2025, 8:04:00 PM)

Premarket: 148.98 +0.54 (+0.36%)

148.44

-5.7 (-3.7%)

Sector
GICS SectorHealth Care
GICS IndustryPharmaceuticals
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryPharmaceuticals
Statistics
52 Week High169.99
52 Week Low140.68
Market Cap357.16B
Shares2.41B
Float2.40B
Yearly Dividend4.91
Dividend Yield3.34%
PE14.77
Fwd PE13.28
Earnings (Next)07-16 2025-07-16/bmo
IPO09-25 1944-09-25


JNJ short term performance overview.The bars show the price performance of JNJ in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -1 -2 -3 -4

JNJ long term performance overview.The bars show the price performance of JNJ in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15

The current stock price of JNJ is 148.44 USD. In the past month the price decreased by -3.84%. In the past year, price decreased by -4.01%.

JOHNSON & JOHNSON / JNJ Daily stock chart

JNJ Competitors/Peers

The largest stocks on the US markets in the "Pharmaceuticals" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
LLY ELI LILLY & CO 54.22 707.26B
NVO NOVO-NORDISK A/S-SPONS ADR 19.01 290.31B
NVS NOVARTIS AG-SPONSORED ADR 12.86 211.00B
AZN ASTRAZENECA PLC-SPONS ADR 18.2 209.96B
MRK MERCK & CO. INC. 9.84 192.83B
PFE PFIZER INC 7.12 129.71B
SNY SANOFI-ADR 13.25 122.31B
BMY BRISTOL-MYERS SQUIBB CO 6.35 94.81B
GSK GSK PLC-SPON ADR 6.72 73.55B
ZTS ZOETIS INC 26.65 71.55B
HLN HALEON PLC-ADR 21.77 47.12B
TAK TAKEDA PHARMACEUTIC-SP ADR 25.89 43.18B

About JNJ

Company Profile

JNJ logo image Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. The company is headquartered in New Brunswick, New Jersey and currently employs 138,100 full-time employees. The firm's primary focus is products related to human health and well-being. The firm operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolism. Medicines in this segment are distributed directly to retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment includes a broad portfolio of products used in the orthopedic, surgery, cardiovascular, and vision fields. These products are distributed to wholesalers, hospitals and retailers, and used principally in the professional fields by physicians, nurses, hospitals, eyecare professionals, and clinics.

Company Info

JOHNSON & JOHNSON

One Johnson & Johnson Plaza

New Brunswick NEW JERSEY 08933 US

CEO: A. Gorsky

Employees: 138100

JNJ Company Website

JNJ Investor Relations

Phone: 17325242455

JOHNSON & JOHNSON / JNJ FAQ

What is the stock price of JOHNSON & JOHNSON today?

The current stock price of JNJ is 148.44 USD. The price decreased by -3.7% in the last trading session.


What is the ticker symbol for JOHNSON & JOHNSON stock?

The exchange symbol of JOHNSON & JOHNSON is JNJ and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is JNJ stock listed?

JNJ stock is listed on the New York Stock Exchange, Inc. exchange.


What is the price forecast or stock price prediction for JOHNSON & JOHNSON stock?

30 analysts have analysed JNJ and the average price target is 174.19 USD. This implies a price increase of 17.35% is expected in the next year compared to the current price of 148.44. Check the JOHNSON & JOHNSON stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is JOHNSON & JOHNSON worth?

JOHNSON & JOHNSON (JNJ) has a market capitalization of 357.16B USD. This makes JNJ a Mega Cap stock.


How many employees does JOHNSON & JOHNSON have?

JOHNSON & JOHNSON (JNJ) currently has 138100 employees.


What are the support and resistance levels for JOHNSON & JOHNSON (JNJ) stock?

JOHNSON & JOHNSON (JNJ) has a support level at 145.6 and a resistance level at 154.61. Check the full technical report for a detailed analysis of JNJ support and resistance levels.


Is JOHNSON & JOHNSON (JNJ) expected to grow?

The Revenue of JOHNSON & JOHNSON (JNJ) is expected to grow by 2.89% in the next year. Check the estimates tab for more information on the JNJ EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy JOHNSON & JOHNSON (JNJ) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does JOHNSON & JOHNSON (JNJ) stock pay dividends?

JOHNSON & JOHNSON (JNJ) has a dividend yield of 3.34%. The yearly dividend amount is currently 4.91. Check the full fundamental report for a detailed analysis of JNJ dividend history, reliability and sustainability.


When does JOHNSON & JOHNSON (JNJ) report earnings?

JOHNSON & JOHNSON (JNJ) will report earnings on 2025-07-16, before the market open.


What is the Price/Earnings (PE) ratio of JOHNSON & JOHNSON (JNJ)?

The PE ratio for JOHNSON & JOHNSON (JNJ) is 14.77. This is based on the reported non-GAAP earnings per share of 10.05 and the current share price of 148.44 USD. Check the full fundamental report for a full analysis of the valuation metrics for JNJ.


What is the Short Interest ratio of JOHNSON & JOHNSON (JNJ) stock?

The outstanding short interest for JOHNSON & JOHNSON (JNJ) is 0.82% of its float. Check the ownership tab for more information on the JNJ short interest.


JNJ Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

JNJ Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to JNJ. While JNJ has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

JNJ Financial Highlights

Over the last trailing twelve months JNJ reported a non-GAAP Earnings per Share(EPS) of 10.05. The EPS decreased by -3.92% compared to the year before.


Industry RankSector Rank
PM (TTM) 24.41%
ROA 11.26%
ROE 27.92%
Debt/Equity 0.63
Chartmill High Growth Momentum
EPS Q2Q%2.21%
Sales Q2Q%2.39%
EPS 1Y (TTM)-3.92%
Revenue 1Y (TTM)4.3%

JNJ Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 74% to JNJ. The Buy consensus is the average rating of analysts ratings from 30 analysts.

For the next year, analysts expect an EPS growth of 6.71% and a revenue growth 2.89% for JNJ


Ownership
Inst Owners73.73%
Ins Owners0.04%
Short Float %0.82%
Short Ratio2.04
Analysts
Analysts74
Price Target174.19 (17.35%)
EPS Next Y6.71%
Revenue Next Year2.89%